Skip to main content
Year archive

AFT Pharmaceuticals Limited — 2025 filings

All 19 regulatory filings released by AFT Pharmaceuticals Limited (AFT) in 2025, sourced directly from the official regulator.

19 Filings
2025 Period
2025 filings (19)
Filing Released Lang
AFT delivers 10th consecutive first half revenue increase
Interim / Quarterly Report
2025-11-19 English
AFT CFO Malcolm Tubby to retire; Simon Bosley CFO Designate
Board/Management Information
2025-11-18 English
AFT to announce half year interim results Nov 20
Report Publication Announcement
2025-10-23 English
September Quarter FY2026 Investor Update
Interim / Quarterly Report
2025-09-24 English
Disclosure of Directors and Senior Managers Relevant Int
Director's Dealing
2025-09-01 English
Results of 2025 Annual Shareholder Meeting
Declaration of Voting Results & Voting Rights Announcements
2025-08-03 English
2025 ASM Release, Chairs address & presentation
AGM Information
2025-07-31 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2025-07-03 English
June Quarter FY 2026 Investor Update
Investor Presentation
2025-06-30 English
Disclosure of Directors and Senior Managers Relevant Intere
Director's Dealing
2025-06-26 English
Notice of Annual Meeting of Shareholders 2025
AGM Information
2025-06-26 English
Annual Meeting and Closing Date for Director Nominations
AGM Information
2025-05-29 English
AFT and Hikma extend US Maxigesic Cooperation
Capital/Financing Update
2025-05-25 English
Corrected Distribution Notice
Notice of Dividend Amount
2025-05-22 English
AFT sees strong FY 26 as revenue reaches new record
Annual Report
2025-05-21 English
AFT to announce full year results on Thursday May 22 2025
Earnings Release
2025-04-30 English
March investor update
Investor Presentation
2025-03-30 English
ASX Small Cap presentation 250326
Investor Presentation
2025-03-25 English
NEW YEAR LETTER TO INVESTORS
Management Reports
2025-01-12 English